Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 11.76B | 11.01B | 10.94B | 10.93B | 9.56B |
Gross Profit | 6.83B | 7.92B | 7.68B | 7.82B | 6.91B |
EBITDA | 5.21B | 7.20B | 7.08B | 7.26B | -728.00M |
Net Income | 1.61B | 2.81B | 2.72B | 2.59B | -1.54B |
Balance Sheet | |||||
Total Assets | 234.97B | 231.45B | 226.54B | 238.03B | 224.75B |
Cash, Cash Equivalents and Short-Term Investments | 10.82B | 6.34B | 5.79B | 9.14B | 6.79B |
Total Debt | 58.06B | 50.97B | 46.25B | 46.22B | 39.10B |
Total Liabilities | 82.28B | 76.54B | 71.33B | 73.54B | 65.41B |
Stockholders Equity | 95.78B | 94.36B | 92.82B | 95.84B | 92.11B |
Cash Flow | |||||
Free Cash Flow | 5.04B | 3.91B | 378.00M | -1.14B | -546.00M |
Operating Cash Flow | 5.21B | 4.02B | 3.10B | 1.74B | 2.58B |
Investing Cash Flow | -3.07B | -2.85B | -4.18B | -1.95B | -2.57B |
Financing Cash Flow | 2.38B | -566.00M | -1.93B | 3.63B | 3.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | HK$19.61B | 13.79 | 1.48% | 6.06% | -9.78% | -29.50% | |
69 Neutral | HK$134.11B | 21.30 | 1.94% | 6.58% | -7.64% | -32.01% | |
59 Neutral | HK$11.01B | ― | -3.12% | 5.88% | 2.20% | -327.14% | |
57 Neutral | $16.28B | ― | -10.34% | 7.72% | -56.64% | -3398.20% | |
53 Neutral | $1.19B | 3.49 | -2.22% | 6.01% | -2.19% | -157.35% | |
47 Neutral | $2.11B | ― | -2.65% | ― | 11.74% | -21.82% | |
46 Neutral | €7.40B | ― | -0.98% | 1.36% | 48.92% | -176.75% |
Hang Lung Group Limited announced an interim dividend of HKD 0.21 per share for the six months ending 30 June 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to shareholders, potentially strengthening its position in the real estate market.
Hang Lung Group Limited has announced its interim results for 2025, detailing the company’s financial performance and operational review. The announcement provides insights into the company’s current financial standing and operational strategies, which may influence its market positioning and stakeholder interests.
Hang Lung Group Limited has announced that its board of directors will convene on July 30, 2025, to approve the interim results for the first half of the year and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns for shareholders, reflecting its strategic positioning in the real estate market.